Stockreport

FDA on board with single Phase 3 to support marketing application for ARCA Bio's Gencaro; shares up 37% premarket [Seeking Alpha]

ARCA biopharma, Inc.  (ABIO) 
US:NASDAQ Investor Relations: arcabio.com/investors
PDF FDA on board with single Phase 3 to support marketing application for ARCA Bio's Gencaro; shares up 37% premarketNano cap ARCA biopharma (NASDAQ:ABIO) is up37% premarket [Read more]